However, TNF-α-stimulated MSCs mainly exhibit anti-tumor capacity, principally by: 1) enhancing the inflammatory response to eliminate tumor cells; 2) releasing tumor apoptotic factors, such as IP10 and TRAIL; and 3) blocking the tumor cell cycle. Here, TNFSF10 is linked to neoplasm.